TriSalus Life Sciences Inc

TLSI
9,85
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/5/202414:00BWTriSalus Reports Q1 2024 Financial Results and Business..
07/5/202413:00BWTriSalus Life Sciences Appoints Liselotte Hyveled to its..
06/5/202422:58BWTriSalus Life Sciences to Host First Quarter 2024 Financial..
30/4/202422:35BWTriSalus Life Sciences Secures up to $50 million of Debt..
01/4/202414:00BWTriSalus Reports Q4 and Full Year 2023 Financial Results and..
26/3/202413:00BWTriSalus Life Sciences Technology Featured in Two..
21/3/202413:00BWTriSalus Life Sciences Announces Oral Presentations at the..
11/3/202422:15BWTriSalus Life Sciences Announces Q4 Conference Call and..
07/3/202413:00BWTriSalus Life Sciences Receives Approval from the World..
29/2/202413:00BWTriSalus Life Sciences Announces Real-World Data..
15/2/202400:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:23EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/1/202423:21EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
25/1/202423:19EDGAR2Form 8-K - Current report
05/1/202422:28EDGAR2Form 8-K - Current report
27/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
26/12/202323:28EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
26/12/202323:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/11/202314:00BWTriSalus Reports Third Quarter 2023 Financial Results and..
07/11/202322:05BWTriSalus Life Sciences to Host Third Quarter 2023 Financial..
04/11/202319:25BWLate-Breaking Phase 1 Liver Metastasis Data from TriSalus..
03/11/202317:00BWTriSalus Life Sciences Presents Data for SD-101 Delivered by..
25/10/202315:05BWTriSalus Life Sciences Announces Late Breaker and Additional..
19/10/202303:58EDGAR2Form S-1/A - General form for registration of securities..
16/10/202323:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/10/202312:01EDGAR2Form 8-K - Current report
06/9/202313:00BWTriSalus Life Sciences Appoints Jodi Devlin as President of..
01/9/202322:47EDGAR2Form S-1/A - General form for registration of securities..
01/9/202322:01EDGAR2Form 8-K - Current report
01/9/202303:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202303:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/8/202323:22EDGAR2Form S-1 - General form for registration of securities under..
29/8/202314:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
21/8/202322:33EDGAR2Form SC 13D - General statement of acquisition of beneficial..
16/8/202322:37EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 9,85

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network